Publicacions
El coneixement generat a IrsiCaixa es comparteix amb la comunitat científica a través de la publicació d’articles a revistes científiques d’alt impacte.
[Resistance profile and genetic barrier of dolutegravir].
HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells.
Discordant Impact of HLA on Viral Replicative Capacity and Disease Progression in Pediatric and Adult HIV Infection.
The Sordid Affair Between Human Herpesvirus and HIV.
Integrase inhibitor (INI) genotypic resistance in treatment-naive and raltegravir-experienced patients infected with diverse HIV-1 clades.
Monotherapy with boosted PIs as an ART simplification strategy in clinical practice.
Targeting Importin-α7 as a Therapeutic Approach against Pandemic Influenza Viruses.
SAMHD1: at the crossroads of cell proliferation, immune responses, and virus restriction.
2015 Update of the Drug Resistance Mutations in HIV-1.
Effect of maraviroc on non-R5 tropic HIV-1: refined analysis of subjects from the phase IIb study A4001029.